anticonvulsants Flashcards

anti-convulsants: recognise that anti-convulsant therapy is determined by the seizure type coupled with pharmacodynamics/pharmacokinetic properties of specific anti-convulsant drugs

1
Q

describe neurotransmission at glutamatergic synapse (increases brain activity, so suppressed by epileptic treatments)

A

voltage-gated Na+ channel (VGSC) opens -> membrane depolarisation -> voltage-gated K+ channel (VGKC) opens -> membrane repolarisation -> Ca2+ influx through voltage-gated calcium channels (VGCCs) -> synaptic vesicle associated (SV2A) protein allows vesicle
attachment to presynaptic membrane -> vesicle exocytosis -> glutamate activates excitatory post-synaptic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 types of ionotropic glutamate excitatory post-synaptic receptors

A

NMDA, AMPA, kainate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 examples of voltage-gated Na+ channel blockers

A

carbamezepine, lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pharmacodynamics of carbamezepine: how it works

A

stabilises inactive state of Na+ channel -> prevents Na+ channel activity -> reduces glutamatergic synapse activity -> membrane depolarisation-> reduces neuronal activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pharmacokinetics of carbamezepine: onset time and half-life

A

enzyme inducer, onset within 1 hour (reasonably fast), 16-30 hour half-life (fairly long)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what seizures is carbamezepine used to treat

A

tonic-clonic seizures, partial seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

when would carbamezepine exhibit severe side-effects

A

if patient has HLA-B1502 allele (causes severe skin conditions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pharmacodynamics of lamotrigine: how it works

A

inactivates Na+ channels -> prevents Na+ channel activity -> reduces glutamatergic synapse activity -> membrane depolarisation -> reduces neuronal activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pharmacokinetics of lamotrigine

A

onset within 1 hour, 24-34 hour half-life (very similar to carbamazepine, and safer during pregnancy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what seizures is lamotrigine used to treat

A

tonic-clonic seizures, absence seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

example of voltage-gated Ca2+ channel blocker

A

ethosuximide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pharmacodynamics of ethosuximide: how it works

A

T-type Ca2+ channel antagonist (present in pacemaker cells and CNS), reducing activity in glutamatergic relay thalamic neurones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacokinetics of ethosuximide: onset and half-life

A

fairly fast onset, long half-life (50 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what seizure is ethosuximide used to treat

A

absence seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2 examples of drugs which inhibit glutamate exocytosis and receptors

A

levetiracetam, topiramate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pharmacodynamics of levetiracetam: how it works

A

binds to synaptic vesicle associated (SV2A) protein, preventing glutamate release

17
Q

pharmacokinetics of levetiracetam: onset and half-life

A

fast onset (1 hour), half-life of 10 hours (smaller duration)

18
Q

what seizure is levetiracetam used to treat

A

myoclonic seizures

19
Q

pharmacodynamics of topiramate: how it works

A

inhibits NMDA and kainate receptors, as well as affecting voltage-gated Na+ channels and GABA receptors (also treats neuropathic pain)

20
Q

pharmacokinetics of topiramate: onset and half-life

A

fast onset (1 hour), long half-life (20 hours)

21
Q

what seizure is topiramate used to treat

A

myoclonic seizures

22
Q

describe neurotransmission at GABAergic synapse (decreases brain activity, so enhanced by epileptic treatments)

A

GABA released -> activates inhibitory post-synaptic GABA-A receptors (Cl- channels) -> membrane hyperpolarisation -> GABA taken up by GAT and metabolised by GABA transaminase (GABA-T) to glutamate

23
Q

when is GABA released

A

tonically, as well as following neuronal stimulation

24
Q

pharmacodynamics of diazepam (benzodiazepines): how it works

A

increases GABA-mediated inhibition

25
Q

pharmacokinetics of diazepam: administration, onset and half-life

A

rectal gel: fast onset (<15 minutes) and half-life of 2 hours (very short); can be given orally

26
Q

what seizure is diazepam used to treat

A

status epilepticus (very fast onset when given rectally)

27
Q

pharmacodynamics of sodium valproate: how it works

A

inhibits GABA transaminase so increases GABA-mediated inhibition and prevents formation of glutamate

28
Q

pharmacokinetics of sodium valproate

A

fast onset (1 hour) and half-life of 12 hours (relatively long)

29
Q

what seizures is sodium valproate used for

A

all forms of epilepsy (can be used in status epilepticus)

30
Q

pharmacological treatment for tonic-clonic seizures

A

carbamazepine, lamotrigine, valproate

31
Q

pharmacological treatment for absence seizures

A

ethosuximide, lamotrigine, valproate

32
Q

pharmacological treatment for tonic/atonic seizures

A

valproate

33
Q

pharmacological treatment for myoclonic seizures

A

levetiracetam, valproate, topiramate

34
Q

pharmacological treatment for status epilepticus

A

diazepam

35
Q

pharmacological treatment for tonic simple and complex partial/focal seizures

A

carbamazepine, lamotrigine, levetiracetam, valproate